Literature DB >> 20725995

Human papillomavirus and survival in patients with base of tongue cancer.

Per Attner1, Juan Du, Anders Näsman, Lalle Hammarstedt, Torbjörn Ramqvist, Johan Lindholm, Linda Marklund, Tina Dalianis, Eva Munck-Wikland.   

Abstract

The incidence of base of tongue cancer is increasing in Sweden and the proportion of human papillomavirus (HPV) positive cancer has increased in Stockholm, Sweden. Between 2006 and 2007, 84% of base of tongue cancer cases in Stockholm were HPV-positive. The objective of this study was to assess the impact of HPV status on prognosis for base of tongue cancer patients. One-hundred and nine patients were diagnosed with base of tongue cancer between 1998 and 2007 in Stockholm County and 95 paraffin-embedded diagnostic tumor biopsies were obtained and tested for HPV by PCR. Eighty-seven patients had available biopsies, were treated with intention to cure and could be included in the survival analysis. Age, sex, TNM-stage, stage, treatment and survival were recorded from patient charts. Kaplan-Meier curves were used to present survival data. In multivariable analyses, a Cox proportional hazards model was used to adjust for covariates. In total 68 (78%) tumor biopsies from the 87 included patients were HPV DNA positive. Kaplan-Meier estimates showed that the overall survival for patients with HPV-positive cancer was significantly better (p = 0.0004), (log-rank test) than that of patients with HPV-negative cancer. Patients with HPV-positive tumors also had significantly better disease-free survival (p = 0.0008), (log-rank test) than those with HPV-negative tumors. These results further strengthen the option to consider HPV-status when planning prospective studies on treatment for base of tongue cancer.
Copyright © 2010 UICC.

Entities:  

Mesh:

Year:  2010        PMID: 20725995     DOI: 10.1002/ijc.25625

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  29 in total

1.  Index-based dietary patterns and risk of head and neck cancer in a large prospective study.

Authors:  Wen-Qing Li; Yikyung Park; Jennifer W Wu; Alisa M Goldstein; Philip R Taylor; Albert R Hollenbeck; Neal D Freedman; Christian C Abnet
Journal:  Am J Clin Nutr       Date:  2014-01-08       Impact factor: 7.045

2.  Adenocarcinoma not otherwise specified on dorsum of tongue: case report and literature review.

Authors:  B A Market Velker; A V Louie; V M Velker; K F Kwan; J H Franklin; V M Venkatesan
Journal:  Curr Oncol       Date:  2012-10       Impact factor: 3.677

3.  Improved survival of Japanese patients with human papillomavirus-positive oropharyngeal squamous cell carcinoma.

Authors:  Takatsugu Mizumachi; Satoshi Kano; Tomohiro Sakashita; Hiromitsu Hatakeyama; Seigo Suzuki; Akihiro Homma; Nobuhiko Oridate; Satoshi Fukuda
Journal:  Int J Clin Oncol       Date:  2012-08-31       Impact factor: 3.402

4.  The prognostic implication of the expression of EGFR, p53, cyclin D1, Bcl-2 and p16 in primary locally advanced oral squamous cell carcinoma cases: a tissue microarray study.

Authors:  Monica Charlotte Solomon; M S Vidyasagar; Donald Fernandes; Vasudev Guddattu; Mary Mathew; Ankur Kaur Shergill; Sunitha Carnelio; Chetana Chandrashekar
Journal:  Med Oncol       Date:  2016-11-05       Impact factor: 3.064

5.  Human papillomavirus is a favourable prognostic factor in cancer of unknown primary in the head and neck region and in hypopharyngeal cancer.

Authors:  Lars Sivars; Cinzia Bersani; Nathalie Grün; Torbjörn Ramqvist; Eva Munck-Wikland; Christian Von Buchwald; Tina Dalianis
Journal:  Mol Clin Oncol       Date:  2016-10-13

6.  Oral dysplasia and squamous cell carcinoma: correlation between increased expression of CD21, Epstein-Barr virus and CK19.

Authors:  Ru Jiang; Xin Gu; Tara N Moore-Medlin; Cherie-Ann Nathan; Lindsey M Hutt-Fletcher
Journal:  Oral Oncol       Date:  2012-04-16       Impact factor: 5.337

7.  Strategies for non-resectable head and neck cancer.

Authors:  Nerina Denaro; Elvio G Russi; Marco C Merlano
Journal:  Curr Treat Options Oncol       Date:  2013-12

8.  In vitro antitumor effects of FGFR and PI3K inhibitors on human papillomavirus positive and negative tonsillar and base of tongue cancer cell lines.

Authors:  Stefan Holzhauser; Ourania N Kostopoulou; Anna Ohmayer; Birthe K A Lange; Torbjörn Ramqvist; Teodora Andonova; Cinzia Bersani; Malin Wickström; Tina Dalianis
Journal:  Oncol Lett       Date:  2019-10-09       Impact factor: 2.967

Review 9.  The clinical impact of HPV tumor status upon head and neck squamous cell carcinomas.

Authors:  Eleni Benson; Ryan Li; David Eisele; Carole Fakhry
Journal:  Oral Oncol       Date:  2013-10-14       Impact factor: 5.337

10.  Cetuximab: its unique place in head and neck cancer treatment.

Authors:  Pol Specenier; Jan B Vermorken
Journal:  Biologics       Date:  2013-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.